Does Ultrasound Guidance Axillary Incision Improve Sentinel Lymph Node Detection in Breast Cancer?
NCT07338721 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2026-01-15
Summary
This single-center randomized controlled trial evaluates whether detecting the first lymph node at the axillary entrance with ultrasound guidance, followed by a targeted axillary incision over the pencil-marked projection, improves sentinel lymph node identification compared to the conventional axillary hairline landmark. The study hypothesizes that this technique enables a smaller incision, minimizes tissue dissection, and reduces operative time.
Conditions
- Breast Carcinoma
- Sentinel Lymph Node Biopsy
Interventions
- PROCEDURE
-
Ultrasound-guided axillary incision group
In the ultrasound-guided axillary incision group, the incision is made at the ultrasound-identified projection of the first lymph node at the axillary entry.
- PROCEDURE
-
The standard axillary incision
In the standard group, the SLNB incision is made parallel to the Langer lines below the axillary hairline.
Sponsors & Collaborators
-
Antalya Training and Research Hospital
lead OTHER_GOV
Principal Investigators
-
Baris R KARAKAS, Assoc. Prof. · Antalya Training and Research Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-01-01
- Primary Completion
- 2026-05-15
- Completion
- 2026-06-15
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Omission of Axillary Lymph Node Dissection in Case of Tumor Spread to Lymph Nodes in the Armpit in Breast Cancer
NCT06869629 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Sentinel Node Biopsy in Breast Cancer: Omission of Axillary Clearance After Macrometastases. A Randomized Trial.
NCT02240472 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Axillary LNs Evalution in Breast Cancer by Multimodal Us
NCT06695052 ·Status: NOT_YET_RECRUITING
-
Sentinel Node Biopsy Alone or With Axillary Dissection After Primary Chemotherapy
NCT04436809 ·Status: COMPLETED ·Phase: NA
-
Axillary Dissection Based on the Histological Result of the Sentinel Node, in Patients With Breast Carcinoma
NCT00970983 ·Status: COMPLETED ·Phase: NA
-
Axillary Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node
NCT01717131 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node Micrometastases
NCT00072293 ·Status: COMPLETED ·Phase: NA
-
Upfront Targeted Axillary Dissection for Luminal Breast Cancer With Limited Axillary Involvement
NCT07278726 ·Status: RECRUITING
-
Ultrasound Guided Core Biopsy vs Fine Needle Aspiration for Evaluation of Axillary Lymphadenopathy
NCT01920139 ·Status: COMPLETED ·Phase: NA
-
SENTINEL LYMPH NODE BIOPSY AFTER NEOADJUVANT CHEMOTHERAPY
NCT04250129 ·Status: UNKNOWN
-
Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer
NCT04671511 ·Status: RECRUITING ·Phase: NA
-
Medico-economic Study of Three Strategies of Sentinel Lymph Node Analysis in Operable Breast Cancer
NCT02056886 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Targeted Axillary Lymph Node Dissection in Node Positive Breast Cancer Patients Post Neo Adjuvant Therapy
NCT05676866 ·Status: UNKNOWN ·Phase: PHASE4
-
Axillary Management After Neoadjuvant Chemotherapy
NCT06096545 ·Status: RECRUITING ·Phase: NA
-
Evaluation Of Lymph Nodes After Neoadjuvant Chemotherapy
NCT02752009 ·Status: WITHDRAWN ·Phase: NA
-
Application of Targeted Axillary Lymph Node Resection in Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: an Open-label, Multicenter Study
NCT07032220 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Axillary Lymph Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node
NCT01796444 ·Status: WITHDRAWN ·Phase: PHASE3
-
Selective Image Guided Resection of Axillary Lymph Nodes
NCT01880645 ·Status: COMPLETED ·Phase: NA
-
Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.
NCT01276054 ·Status: TERMINATED ·Phase: PHASE2
-
Carbon Suspension vs. Metallic Marker for Axillary Lymph Node Marking in Breast Cancer After Neoadjuvant Therapy
NCT07106112 ·Status: RECRUITING ·Phase: NA
-
A Novel Method of Clipped Axillary Lymph Node Localization Post Neoadjuvant Chemotherapy in Breast Cancer Patients .
NCT03878017 ·Status: UNKNOWN ·Phase: NA
-
Sentinel Node Biopsy in Breast Cancner: Omission of Axillary Clearance After Micrometastasis
NCT02049632 ·Status: COMPLETED ·Phase: NA
-
Ambulatory SNP Under Local Anaesthesia in a Subgroup of Breast Cancer Patients - Trial
NCT02187718 ·Status: UNKNOWN ·Phase: NA
-
Lymphedema Evaluation After Adjuvant Hypofractionated Radiotherapy for 1-2 Macrometastatic Sentinel Lymph Nodes
NCT06321653 ·Status: RECRUITING
-
GF-GS 01: Comparing Conventional Axillary Dissection Versus Sentinel Node Resection in Clinically Node-negative Operable Breast Cancer
NCT00144898 ·Status: COMPLETED ·Phase: PHASE3